Summary
Aflac Incorporated reported a decrease in net earnings for the first quarter of 2015 compared to the same period in 2014, primarily driven by a weaker Japanese Yen, which negatively impacted the translation of its substantial Japanese operations into U.S. dollars. Despite the reported net earnings decline, the company's core insurance operations remained robust, with stable benefit ratios and controlled operating expenses in its U.S. segment, while Japan saw increased sales in key medical and cancer products. Financially, Aflac strengthened its capital position by issuing $1 billion in senior notes and used a portion of these proceeds to redeem higher-interest debt, resulting in lower future interest expenses. The company also continued its share repurchase program, demonstrating a commitment to returning capital to shareholders. Management expressed confidence in the company's financial health and its ability to meet future obligations, with key performance indicators remaining strong despite currency headwinds.
Financial Highlights
32 data points| Revenue | $5.23B |
| SG&A Expenses | $530.00M |
| Operating Income | $1.03B |
| Interest Expense | $83.00M |
| Net Income | $663.00M |
| EPS (Basic) | $0.76 |
| EPS (Diluted) | $0.76 |
| Shares Outstanding (Basic) | 874.61M |
| Shares Outstanding (Diluted) | 879.85M |
Key Highlights
- 1Net earnings decreased to $663 million ($1.51 per diluted share) in Q1 2015 from $732 million ($1.60 per diluted share) in Q1 2014, largely due to the weakening Japanese Yen.
- 2Aflac Japan's pretax operating earnings decreased by 12.2% in dollar terms to $819 million, impacted by currency translation, though in yen terms, pretax operating earnings saw a modest increase of 1.8%.
- 3Aflac U.S. experienced a 6.1% decrease in pretax operating earnings to $285 million, primarily due to increased sales-related expenses, while net premium income saw a 3.5% increase.
- 4The company issued $1 billion in senior notes in March 2015 and utilized cross-currency swaps to convert these dollar-denominated obligations into yen-denominated ones, reducing interest expenses.
- 5Shareholder equity included a net unrealized gain on investment securities and derivatives of $5.0 billion at March 31, 2015, up from $4.7 billion at December 31, 2014.
- 6Aflac repurchased approximately 9.8 million shares of common stock for $600 million in the first quarter of 2015, continuing its share repurchase program.
- 7The company maintains a strong capital position, with its Risk-Based Capital (RBC) ratio remaining high, indicating solvency and surplus strength.